FOXC1 and neoplasm: IHC analysis confirmed the reduced levels of Ki67, Gli1, and VEGFR2 in FOXC1-silenced xenograft tumors (Fig. 6e), whereas FOXC1 overexpression upregulated these proliferative and metastatic markers compared with the xenograft tumors from empty vector control tumor group (Fig. 6f).